Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:40:40 UTC 2023
by
admin
on
Sat Dec 16 11:40:40 UTC 2023
|
| Protein Type | RECEPTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
79AAW649HW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
79AAW649HW
Created by
admin on Sat Dec 16 11:40:41 UTC 2023 , Edited by admin on Sat Dec 16 11:40:41 UTC 2023
|
PRIMARY | |||
|
P21452
Created by
admin on Sat Dec 16 11:40:41 UTC 2023 , Edited by admin on Sat Dec 16 11:40:41 UTC 2023
|
PRIMARY | |||
|
P21452
Created by
admin on Sat Dec 16 11:40:41 UTC 2023 , Edited by admin on Sat Dec 16 11:40:41 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_106 | 1_181 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_11 |
| N | 1_19 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR->OFF-TARGET |
Neratinib concentration at 10 microM
INHIBITOR
Percent inhibition of specific binding
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
Tachykinin NK2 receptor antagonist that was developed by Sanofi-Aventis for anti-depressant potential
IC50
|
||
|
INHIBITOR -> TARGET |
Radioligand binding assay
BINDING
IC50
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Ki
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|